DE60136446D1 - Verfahren zur herstellung von amin-derivaten - Google Patents

Verfahren zur herstellung von amin-derivaten

Info

Publication number
DE60136446D1
DE60136446D1 DE60136446T DE60136446T DE60136446D1 DE 60136446 D1 DE60136446 D1 DE 60136446D1 DE 60136446 T DE60136446 T DE 60136446T DE 60136446 T DE60136446 T DE 60136446T DE 60136446 D1 DE60136446 D1 DE 60136446D1
Authority
DE
Germany
Prior art keywords
amine derivatives
secretion
inhibiting
accumulation
action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60136446T
Other languages
English (en)
Inventor
M Yamashita
Kaneyoshi Kato
Hiroyuki Tawada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE60136446D1 publication Critical patent/DE60136446D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
DE60136446T 2000-04-03 2001-04-02 Verfahren zur herstellung von amin-derivaten Expired - Lifetime DE60136446D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000105398 2000-04-03
PCT/JP2001/002845 WO2001074756A1 (fr) 2000-04-03 2001-04-02 Procede de production de derives d'amine

Publications (1)

Publication Number Publication Date
DE60136446D1 true DE60136446D1 (de) 2008-12-18

Family

ID=18618765

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60136446T Expired - Lifetime DE60136446D1 (de) 2000-04-03 2001-04-02 Verfahren zur herstellung von amin-derivaten

Country Status (11)

Country Link
US (1) US6784314B2 (de)
EP (1) EP1270545B1 (de)
KR (1) KR100769504B1 (de)
CN (4) CN100486957C (de)
AT (1) ATE413379T1 (de)
AU (1) AU2001244700A1 (de)
CA (1) CA2404736C (de)
CY (1) CY1108727T1 (de)
DE (1) DE60136446D1 (de)
ES (1) ES2312423T3 (de)
WO (1) WO2001074756A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2471531A1 (en) * 2001-12-26 2003-07-10 Takeda Chemical Industries, Ltd. Agents for treating mild cognitive impairment
RU2372344C2 (ru) * 2004-05-05 2009-11-10 Ф. Хоффманн-Ля Рош Аг Арилсульфонилбензодиоксаны, применяемые для модуляции 5-нт6 рецептора, 5-нт2a рецептора или и того, и другого
EP1760071A4 (de) 2004-06-23 2008-03-05 Ono Pharmaceutical Co Verbindung mit s1p-rezeptorbindungsfähigkeit und verwendung dafür
AU2005318598B2 (en) * 2004-12-21 2010-08-26 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof as 5-HT antagonists
ES2306275T3 (es) * 2004-12-21 2008-11-01 F. Hoffmann-La Roche Ag Derivados de cromano y sus usos como ligandos dde receptores 5-ht.
BRPI0515830A (pt) 2004-12-21 2008-08-05 F Hoffmann La Roche derivados de cromano e usos dos mesmos no tratamento de distúrbios do sistema nervoso central
CN101119965B (zh) * 2004-12-21 2012-09-26 弗·哈夫曼-拉罗切有限公司 萘满和茚满衍生物及其用途
CA2591793A1 (en) * 2004-12-21 2006-06-29 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
DE602006020351D1 (en) * 2005-11-03 2011-04-07 Hoffmann La Roche Arylsulfonylchromane als 5-ht6-inhibitoren
JP2009541249A (ja) * 2006-06-20 2009-11-26 エフ.ホフマン−ラ ロシュ アーゲー アリールスルホニルナフタレン誘導体およびその使用
AU2007263084A1 (en) * 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
CA2655524A1 (en) * 2006-06-20 2007-12-27 F. Hoffman-La Roche Ag Arylsulfonamidyl tetralin derivatives and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3630903A1 (de) 1986-09-11 1988-03-24 Thomae Gmbh Dr K Neue tetrahydronaphthalin- und indanderivate, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
DE3807813A1 (de) 1988-03-10 1989-09-21 Thomae Gmbh Dr K Neue benzocycloheptenderivate, diese verbindungen enthaltende arzneimittel und verfahren zu deren herstellung
DE3901814A1 (de) 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
CA2105067C (en) 1991-03-01 2002-05-14 Kiyoshi Yoshida Indan derivative and thromboxane antagonist containing the same
WO1995032967A1 (en) 1994-05-28 1995-12-07 Smithkline Beecham Plc Amide derivatives having 5ht1d-antagonist activity
ES2098186B1 (es) 1995-02-09 1998-02-01 Consejo Superior Investigacion Composiciones farmaceuticas a base de aminometilindoles para su aplicacion terapeutica como neuroprotectores en las enfermedades de parkinson y alzheimer.
WO1998006691A2 (en) 1996-08-14 1998-02-19 Warner-Lambert Company Low molecular weight dendritic compounds as pharmaceutical agents
US6048877A (en) 1997-02-21 2000-04-11 Bristol-Myers Squibb Company Tetralone derivatives as antiarrhythmic agents
ATE390404T1 (de) * 1997-02-27 2008-04-15 Takeda Pharmaceutical Aminderivate, ihre herstellung und verwendung als inhibitoren der produktion von amyloid-beta
JP3868096B2 (ja) * 1997-02-27 2007-01-17 武田薬品工業株式会社 アミン誘導体、その製造法および剤
JP4367982B2 (ja) * 1997-07-18 2009-11-18 武田薬品工業株式会社 光学異性体の製造法

Also Published As

Publication number Publication date
ES2312423T3 (es) 2009-03-01
EP1270545A1 (de) 2003-01-02
ATE413379T1 (de) 2008-11-15
EP1270545A4 (de) 2005-10-12
CN100486957C (zh) 2009-05-13
CN1680332A (zh) 2005-10-12
EP1270545B1 (de) 2008-11-05
CN100349872C (zh) 2007-11-21
US20030139602A1 (en) 2003-07-24
KR20020089424A (ko) 2002-11-29
CN1422244A (zh) 2003-06-04
KR100769504B1 (ko) 2007-10-23
CN1680280A (zh) 2005-10-12
CY1108727T1 (el) 2014-04-09
CA2404736C (en) 2011-12-06
AU2001244700A1 (en) 2001-10-15
CN101058543A (zh) 2007-10-24
US6784314B2 (en) 2004-08-31
CN101058543B (zh) 2010-05-26
CA2404736A1 (en) 2002-10-02
WO2001074756A1 (fr) 2001-10-11

Similar Documents

Publication Publication Date Title
CY1108727T1 (el) Διαδικασια παραγωγης αμινικων παραγωγων
DE69534029D1 (de) Herstellung von Camptothecinderivaten durch intramolekulare Cyclisierung
DE60224536D1 (de) Verfahren zur herstellung von l-aminosäuren unter verwendung von stämmen aus der familie der enterobacteriaceae
ATE273295T1 (de) Verfahren zur herstellung von 6-substituierten (s)-nikotin-derivaten und zwischenverbindungen
ATE234294T1 (de) Verfahren zur herstellung von n-(4-cyan-3- trifluormethylphenyl)-3-(4-flurophenylsulfonyl) 2-hydroxy-2-methylpropionamid
ATE231160T1 (de) Erythromycin-derivate, ihr verfahren zur herstellung und ihre verwendung als arzneimittel
DE60132053D1 (de) Verfahren zur herstellung von amidverbindungen
DE60125378D1 (de) Verfahren zur herstellung von 2-aminomethyl-halogen-pyridinen
ATE213492T1 (de) Verfahren zur herstellung von racemisch sertralin
DE60104381D1 (de) Verfahren zur Herstellung von einer Amid Verbindung
ID23360A (id) PROSE DAN ZAT ANTARA UNTUK SUATU AGONIS RESEPTOR β<3>-ADRENERGIK
ATE282594T1 (de) Verfahren zur herstellung von (+)-trans-4-p- fluorophenyl-3-hydroxymethyl-1-methylpiperidin
DE60106778D1 (de) Verfahren zur herstellung von vitronectin-rezeptorantagonisten
DE60039533D1 (de) Verbessertes verfahren zur herstellung von 2s,3s-n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamid hydrochlorid und anderen derivaten von 2-hydroxy-1,3-diamin
ATE258161T1 (de) Verfahren zur herstellung von chiralen aminosäuren
ATE221070T1 (de) Verfahren zur herstelung von pirlindolehydrochlorid
DE59909775D1 (de) Verfahren zur Herstellung von Sechsring-Carbocyclen
DE60001298D1 (de) Verfahren zur Herstellung von Omeprazol
DE69724216D1 (de) Pyridin-Zwischenprodukte, verwendbar zur Herstellung von Beta-adrenergischen Rezeptor-Agonisten
DE60028998D1 (de) Verfahren zur herstellung einer benzylamin-verbindung
ATE129231T1 (de) Verfahren zur herstellung von optisch aktiven norbornylaminderivaten.
DE50114758D1 (de) Verfahren zur herstellung von indolen
DE69921795D1 (de) Verfahren zur herstellung von benzothiophencarbonsäureamid-derivaten
ATE404540T1 (de) Verfahren zur herstellung von 1-substituierten 5- chlor-4methylpyrazolen
DE69912282D1 (de) Verfahren zur herstellung eines indolderivates

Legal Events

Date Code Title Description
8364 No opposition during term of opposition